Archive › Research

Reanalysis of Clinical Trial Data Confirms LipiGesic® M has Robust Efficacy for Treatment of Migraine Headache and Associated Symptoms

PuraMed BioScience®, Inc., (PMBS: OTCBB) announces that the reanalysis of the clinical trial results of its homeopathic formulation, LipiGesic® M, found that the migraine medication has “robust efficacy.” These results were  featured in the February 2013 issue of Headache: The Journal of Head and Face Pain, the official journal of the American Headache Society®. The [...]

Comments Off

PuraMed BioScience® Announces It Has Commenced a Clinical Study of LipiGesic®M for Children

Schofield, Wis., February 7, 2012 – PuraMed BioScience, Inc. (OTC QB: PMBS) announced today that it has recently commenced a clinical study of its unique non –prescription migraine treatment, LipiGesic®M on children and adolescents.  Currently there are no prescription migraine medications recommended for those under the age of 18, and PuraMed hopes to attract that [...]

Comments Off

A Double-Blind Placebo-Controlled Pilot Study of Sublingual Feverfew and Ginger (LipiGesic® M) in the Treatment of Migraine

Roger K. Cady, MD, Jerome Goldstein, MD, Robert Nett, MD, Russell Mitchell, M.E. Beach, BS LPN, CCRP; Rebecca Browning, BS Headache Care Center, Springfield, MO BACKGROUND Therapeutic needs of migraineurs vary considerably from patient to patient and even attack to attack. Some attacks require high-end therapy, while other attacks have treatment needs that are less [...]

Comments ( 1 )